Oragenics Inc. Files 8-K Report

Ticker: OGEN · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1174940

Oragenics INC 8-K Filing Summary
FieldDetail
CompanyOragenics INC (OGEN)
Form Type8-K
Filed DateMar 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, financials

Related Tickers: ORGN

TL;DR

ORGN filed an 8-K on 3/6/25 covering other events and financials.

AI Summary

On March 6, 2025, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing signals that Oragenics, Inc. is providing updated information to the SEC, which could include material business developments or financial disclosures relevant to investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification without specific details on material events, financial performance, or significant changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Oragenics, Inc.?

The 8-K filing on March 6, 2025, is for "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's operations and financial status.

What is Oragenics, Inc.'s state of incorporation and IRS Employer Identification Number?

Oragenics, Inc. is incorporated in Florida (FL) and its IRS Employer Identification Number is 59-3410522.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on March 6, 2025.

What is the principal executive office address for Oragenics, Inc.?

The principal executive office address for Oragenics, Inc. is 1990 Main Street, Suite 750, Sarasota, FL 34236.

What is Oragenics, Inc.'s standard industrial classification code?

Oragenics, Inc.'s standard industrial classification code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding ORAGENICS INC (OGEN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing